JPMorgan Chase & Co. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by JPMorgan Chase & Co. on February 7, 2008. The filing serves to incorporate specific tax opinions by reference into the company's Registration Statement on Form S-3ASR (File No. 333-130051).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing regarding exhibits and does not contain financial performance data.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing solely addresses the submission of legal tax opinions related to specific structured note offerings.
Guidance, Outlook, and Unusual Items
The filing details the inclusion of four tax opinions from Davis Polk & Wardwell regarding the following structured notes:
- 9.425% Reverse Exchangeable Notes due August 12, 2008, linked to LM Ericsson Telephone Company.
- 9.30% Reverse Exchangeable Notes due February 12, 2009, linked to GlaxoSmithKline plc.
- Return Enhanced Notes linked to the Dow Jones EURO STOXX 50 Index due August 13, 2008.
- 6.50% Reverse Exchangeable Notes due May 13, 2008, linked to Target Corporation.
No management commentary, forward-looking guidance, or risk factors are disclosed in this specific filing.
Investor Verification Checklist
- Verify the terms and risks of the structured notes listed in the exhibit index.
- Review the full Registration Statement on Form S-3ASR (333-130051) for complete offering details.
- Consult the referenced tax opinions (Exhibits 8.1 through 8.4) for specific tax implications of the notes.
- Note that this filing contains no financial results; refer to the most recent 10-K or 10-Q for performance metrics.